Promising Biotech Companies in Europe


Regular Price: USD 4,950.00

Special Price USD 3,465.00

30% OFF

* Required Fields

Regular Price: USD 4,950.00

Special Price USD 3,465.00


Be the first to review this product

This research service aims to profile some of the promising biotech companies in Europe across different countries and segments.

Table of Contents

Promising Biotech Companies in Europe, IntroductionBiotechnology Industry—EuropeOverviewResearch and Development ProcessApplication AreasProtein Therapeutics and Monoclonal AntibodiesGene Therapy and Anti SensePromising Biotech Companies in Europe, Promising Companies - ProfilesProfilesAffibodyAntisomaAstex Therapeutics Bavarian NordicBioInventBiotageBiovitrumCrucellFlamel TechnologiesGPC BiotechImmatics BiotechnologiesInnogeneticsIntercytexMedigeneMerialNeuroSearchNovozymesRenovoSantaris PharmaSartorius Stedium BiotechTopoTargetTransgeneVernalisPromising Biotech Companies in Europe, ConclusionFuture of Biotech in EuropeBiotechnology Post Recession—How will it Be AffectedPromising Biotech Companies in Europe, Decision Support DatabasesDatabases UsedNumber of Biotechnology CompaniesPharmaceutical R&D ExpenditureEPO Biotechnology PatentsGovernment R & D Investment in BiotechnologyVenture Capital Investment in Biotechnology

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.